BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2010273)

  • 1. Chronic active hepatitis following splenectomy for autoimmune thrombocytopenia.
    Levene NA; Varon D; Shtalrid M; Berrebi A
    Isr J Med Sci; 1991 Apr; 27(4):199-201. PubMed ID: 2010273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple autoimmune manifestations in a splenectomized subject with HLA-B8.
    Kleiner-Baumgarten A; Schlaeffer F; Keynan A
    Arch Intern Med; 1983 Oct; 143(10):1987-9. PubMed ID: 6605130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy for immune thrombocytopenic purpura: Auckland experience 1979-87.
    Shaw JH; Clark MA
    Aust N Z J Surg; 1989 Feb; 59(2):123-6. PubMed ID: 2919996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
    Numeroso F; Baroni MC; Delsignore R
    Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of splenectomy on antinuclear and anti-native DNA antibody titer in patients with idiopathic thrombocytopenic purpura].
    Poborski W
    Pol Tyg Lek; 1988 Jul; 43(30):968-70. PubMed ID: 3070498
    [No Abstract]   [Full Text] [Related]  

  • 9. Grand rounds. Immune globulin in the treatment of autoimmune thrombocytopenic purpura.
    Wordell CJ; Stubits EA; Tietze KJ; Gaska JA; Cosgrove EM
    Clin Pharm; 1985; 4(2):206-13. PubMed ID: 4039241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenectomy in chronic hepatitis with an autoimmune component].
    Burlui D; Constantinescu C; Dragoncea C; Pascaru R; Lenkei R; Cristian R
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1979; 28(2):93-100. PubMed ID: 461876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenic purpura in patients with hepatitis C virus infection.
    Nakajima H; Takagi H; Yamazaki Y; Toyoda M; Takezawa J; Nagamine T; Mori M
    Hepatogastroenterology; 2005; 52(64):1197-200. PubMed ID: 16001660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Splenectomy in the treatment of idiopathic thrombocytopenic purpura].
    Colović M; Colović R; Tomasević IR
    Acta Chir Iugosl; 1989; 36(1):7-14. PubMed ID: 2711807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of chronic active hepatitis of the autoimmune type following hepatitis B virus infection with HBSAg-persistence. 4 case reports].
    Hopf U; Möller B
    Z Gastroenterol; 1984 Mar; 22(3):121-8. PubMed ID: 6719967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
    Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
    Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune thrombocytopenia and diffuse-toxic goiter].
    Mogucheva EI; Idel'son LI; Granovskaia-Tsvetkova AM; Romashov FN; Alekseev GI
    Ter Arkh; 1985; 57(7):79-84. PubMed ID: 3840284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kaleidoscopic autoimmunity].
    Shoenfeld Y
    Harefuah; 1998 Oct; 135(7-8):262-4, 336. PubMed ID: 9885669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.